Search research articles
Contact Us
Filters
Showing results (111-120 of 147) with videos related to
Page
of 15
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
April 1, 1995
Actions of neurotoxins (bungarotoxins, neosurugatoxin and lophotoxins) on insect and nematode nicotinic acetylcholine receptors
C Tornøe, D Bai, L Holden-Dye, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Distinctions in ligand binding sites on the nicotinic acetylcholine receptor
P Taylor, S N Abramson, D A Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide
N Abramson, P K Stokes, Mathew Luke, et al.
Epidemiology and Infection
|
July 31, 2007
Invasive meningococcal disease in children in Jerusalem
C Stein-Zamir, N Abramson, G Zentner, et al.
JAMA
|
December 22, 1989
Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group
M Jastremski, K Sutton-Tyrrell, P Vaagenes, et al.
The New England Journal of Medicine
|
February 12, 1970
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3)
C A Alper, N Abramson, R B Johnston, et al.
The Journal of Clinical Investigation
|
November 1, 1970
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection
C A Alper, N Abramson, R B Johnston, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 15, 2010
Mumps outbreak in Jerusalem affecting mainly male adolescents
C Stein-Zamir, H Shoob, N Abramson, et al.
Cancer Treatment Reports
|
June 1, 1982
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma
N Abramson, P Lurie, W L Mietlowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1971
Deficiency of C3 inactivator in man
N Abramson, C A Alper, P J Lachmann, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 147) with videos related to
Sort By:
Page
of 15
Toxicon : Official Journal of the International Society on Toxinology
|
April 1, 1995
Actions of neurotoxins (bungarotoxins, neosurugatoxin and lophotoxins) on insect and nematode nicotinic acetylcholine receptors
C Tornøe, D Bai, L Holden-Dye, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Distinctions in ligand binding sites on the nicotinic acetylcholine receptor
P Taylor, S N Abramson, D A Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide
N Abramson, P K Stokes, Mathew Luke, et al.
Epidemiology and Infection
|
July 31, 2007
Invasive meningococcal disease in children in Jerusalem
C Stein-Zamir, N Abramson, G Zentner, et al.
JAMA
|
December 22, 1989
Glucocorticoid treatment does not improve neurological recovery following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group
M Jastremski, K Sutton-Tyrrell, P Vaagenes, et al.
The New England Journal of Medicine
|
February 12, 1970
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3)
C A Alper, N Abramson, R B Johnston, et al.
The Journal of Clinical Investigation
|
November 1, 1970
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection
C A Alper, N Abramson, R B Johnston, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 15, 2010
Mumps outbreak in Jerusalem affecting mainly male adolescents
C Stein-Zamir, H Shoob, N Abramson, et al.
Cancer Treatment Reports
|
June 1, 1982
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma
N Abramson, P Lurie, W L Mietlowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1971
Deficiency of C3 inactivator in man
N Abramson, C A Alper, P J Lachmann, et al.
Page
of 15